IP Library Patent Application 14149616
Patent Application
App. No. 14/149,616

INJECTOR AUTO PURGE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/149,616
Abstract

An auto purge for an intravenous contrast injector of the type having a motor which advances a plunger drive ram and configured for use with a pre-filled or user-filled syringe containing an approximate known amount of air including a processor which causes the motor to move and a memory storing a predetermined purge stop point representative of the approximate known amount of air in the syringe, the injector configured to automatically advance the plunger drive ram an amount substantially equal to the predetermined purge stop point representative of the approximate known amount of air contained in the syringe.

Claims (37)

1 - 34 . (canceled)

35 . A method of executing a purge sequence for an injector, the method comprising:

receiving first user input at said injector;

purging gas from a first syringe installed on said injector, wherein said purging comprises advancing a plunger drive ram to a first purge stop point and in response to said first user input, wherein said plunger drive ram is stopped at said first purge stop point by said injector;

receiving second user input at said injector after said plunger drive ram has been stopped at said first purge stop point;

manually controlling advancement of said plunger drive ram to a second purge stop point where said plunger drive ram is stopped, wherein said purging further comprises said manually controlling advancement, and wherein said manually controlling advancement is in response to and based upon said second user input;

fluidly connecting a patient with said first syringe after a termination of said purging; and

injecting fluid from said first syringe into said patient after said fluidly connecting.

36 . The method of claim 35 , wherein said receiving first user input is through activation of a purge button on said injector.

37 . The method of claim 35 , wherein said manually controlling advancement comprises an operator using a control of said injector that is operatively connected with said plunger drive ram.

38 . The method of claim 35 , wherein said first syringe is filled with fluid before said first syringe is installed on said injector.

39 . The method of claim 35 , further comprising:

filling said first syringe with fluid after said syringe has been installed on said injector, wherein said purging is executed after said filling.

40 . The method of claim 35 , further comprising:

enabling said injector after a termination of said purging, wherein said injecting is executed after said enabling, and wherein said enabling comprises receiving third user input at said injector.

41 . The method of claim 35 , further comprising:

said injector monitoring an orientation of said first syringe, wherein said purging may be initiated only if said monitoring determines that a discharge tip of said first syringe is pointing in an upward direction.

42 . The method of claim 35 , further comprising:

determining parameters for said first syringe installed on said injector, wherein said first purge stop point is based upon said determining.

43 . The method of claim 42 , wherein said determining is executed by said injector.

44 . The method of claim 43 , wherein said determining comprises said injector identifying a face plate installed on said injector, and wherein said first syringe is installed on said injector using said face plate.

45 . The method of claim 35 , further comprising:

receiving user input syringe parameters at said injector, wherein said user input syringe parameters are for said first syringe installed on said injector, and wherein said first purge stop point is based upon said user input syringe parameters.

46 . The method of claim 35 , further comprising:

said injector retrieving syringe parameters from memory of said injector, wherein said first purge stop point is based upon said syringe parameters from said retrieving.

47 . The method of claim 35 , further comprising:

said injector monitoring contents of said first syringe at a first location, wherein said first purge stop point is based upon said monitoring.

48 . The method of claim 47 , wherein said advancing step continues while said monitoring identifies air at said first location, and wherein a termination of said advancing is based upon said monitoring identifying fluid at said first location.

49 . The method of claim 47 , wherein said monitoring uses an air detection module associated with a discharge neck of said first syringe.

50 . The method of claim 35 , wherein a second syringe is installed on said injector, wherein a first section of Y-tubing is coupled to said first syringe, wherein a second section of said Y-tubing is coupled to said second syringe, wherein said Y-tubing further comprises a third section, wherein said first, second, and third sections meet at an intersection, wherein each of said first and second sections feed into said third section, wherein said first purge stop point is associated with a location that is short of said intersection of said first, second, and third sections of said Y-tubing, and wherein said second purge stop point is at said intersection of said first, second, and third sections of said Y-tubing.

51 . The method of claim 50 , further comprising:

receiving third user input at said injector after said plunger drive ram has been stopped at said second purge stop point;

purging gas from said second syringe, wherein said purging in relation to said second syringe comprises advancing a second plunger drive ram to a third purge stop point and in response to said third user input, wherein said second plunger drive ram is stopped at said third purge stop point by said injector;

receiving fourth user input at said injector after said second plunger drive ram has been stopped at said third purge stop point;

manually controlling advancement of said second plunger drive ram to a fourth purge stop point where said second plunger drive ram is stopped, wherein said purging in relation to said second syringe further comprises said manually controlling advancement of said second plunger drive ram, and wherein said manually controlling advancement is in response to and based upon said fourth user input.

52 . The method of claim 51 , wherein said receiving third user input is through activation of a purge button on said injector.

53 . The method of claim 51 , wherein said manually controlling advancement in relation to said second plunger drive ram comprises an operator using a control of said injector that is operatively connected with said second plunger drive ram.

Assignments (4)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →